ES8404858A1 - Un procedimiento para la purificacion de un anticuerpo. - Google Patents
Un procedimiento para la purificacion de un anticuerpo.Info
- Publication number
- ES8404858A1 ES8404858A1 ES521371A ES521371A ES8404858A1 ES 8404858 A1 ES8404858 A1 ES 8404858A1 ES 521371 A ES521371 A ES 521371A ES 521371 A ES521371 A ES 521371A ES 8404858 A1 ES8404858 A1 ES 8404858A1
- Authority
- ES
- Spain
- Prior art keywords
- monoclonal antibodies
- affinity purification
- antibodies
- antigens
- environment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title abstract 3
- 238000001261 affinity purification Methods 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 abstract 4
- 102000036639 antigens Human genes 0.000 abstract 4
- 108091007433 antigens Proteins 0.000 abstract 4
- 102000002265 Human Growth Hormone Human genes 0.000 abstract 1
- 108010000521 Human Growth Hormone Proteins 0.000 abstract 1
- 239000000854 Human Growth Hormone Substances 0.000 abstract 1
- 230000002411 adverse Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000000984 immunochemical effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
METODO DE PURIFICACION DE ANTICUERPOS CON GRAN AFINIDAD POR UN ANTIGENO EN UN PRIMER MEDIO AMBIENTE Y BAJA AFINIDAD POR EL MISMO EN UN SEGUNDO MEDIO AMBIENTE.CONSISTE EN INMOVILIZAR EL ANTIGENO SOBRE UN SOPORTE SOLIDO; FIJAR EL ANTICUERPO AL ANTIGENO EN EL PRIMER MEDIO AMBIENTE QUE TIENE UN PH ENTRE 4 Y 10,5, SEPARAR LAS IMPUREZAS NO FIJADAS DESDE EL ANTICUERPO; Y ELUIR EL ANTICUERPO PURO DESDE EL ANTIGENO MEDIANTE UN ELUYENTE, CONSTITUIDO POR UN SEGUNDO MEDIO AMBIENTE QUE ES UNA DISOLUCION QUE CONTIENE UN AGENTE CAOTROPICO A OTRO PH ENTRE 4 Y 10,5.ESTOS COMPUESTOSTIENEN APLICACIONES FARMACOLOGICAS POR SUS PROPIEDADES INMUNOQUIMICAS Y/O BIOLOGICAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36778182A | 1982-04-12 | 1982-04-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES521371A0 ES521371A0 (es) | 1984-05-16 |
ES8404858A1 true ES8404858A1 (es) | 1984-05-16 |
Family
ID=23448565
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES521371A Expired ES8404858A1 (es) | 1982-04-12 | 1983-04-11 | Un procedimiento para la purificacion de un anticuerpo. |
ES528001A Expired ES8706964A1 (es) | 1982-04-12 | 1983-12-13 | Un procedimiento para fraccionar anticuerpos de suero. |
ES528000A Granted ES528000A0 (es) | 1982-04-12 | 1983-12-13 | Un procedimiento para la purificacion de un antigeno. |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES528001A Expired ES8706964A1 (es) | 1982-04-12 | 1983-12-13 | Un procedimiento para fraccionar anticuerpos de suero. |
ES528000A Granted ES528000A0 (es) | 1982-04-12 | 1983-12-13 | Un procedimiento para la purificacion de un antigeno. |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0105359A4 (es) |
AT (1) | AT393386B (es) |
AU (1) | AU622099B2 (es) |
CA (1) | CA1209907A (es) |
CH (1) | CH672028A5 (es) |
DK (1) | DK192191D0 (es) |
ES (3) | ES8404858A1 (es) |
FI (1) | FI88403C (es) |
GB (1) | GB2128630B (es) |
IT (1) | IT1219779B (es) |
WO (1) | WO1983003678A1 (es) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8328918D0 (en) * | 1983-10-28 | 1983-11-30 | Unilever Plc | Alkaline phosphatase |
GB8331071D0 (en) * | 1983-11-22 | 1983-12-29 | Karayiannis P | Assay for dna/rna |
US4666865A (en) * | 1984-01-13 | 1987-05-19 | Centocor, Inc. | Immunoassay for biologically active human interferon-gamma employing unique monoclonal antibodies |
US4789631A (en) * | 1984-02-17 | 1988-12-06 | Synbiotics Corporation | Immunoassay for anti-dirofilaria immitis antibody |
GB8426468D0 (en) * | 1984-10-19 | 1984-11-28 | Technology Licence Co Ltd | Monoclonal antibodies |
AU5259786A (en) * | 1985-01-30 | 1986-08-07 | United States Of America, The | Monoclonal antibodies against chlamydial genes specific lipopolysaccharide |
US4818687A (en) * | 1985-02-28 | 1989-04-04 | Massachusetts Institute Of Technology | Affinity column and process for detection of low molecular weight toxic substances |
US4859611A (en) * | 1985-02-28 | 1989-08-22 | Massachusetts Institute Of Technology | Affinity column and process for detection of low molecular weight toxic substances |
IL75828A (en) * | 1985-07-17 | 1991-06-10 | Univ Ramot | Immobilization by biologically active proteins |
NZ218336A (en) * | 1985-12-09 | 1991-08-27 | Kirin Amgen Inc | Monoclonal antibodies to human pluripotent granulocyte colony stimulating factor (hpg-csf) |
US5175255A (en) * | 1987-03-23 | 1992-12-29 | Amgen Inc. | Methods for purification of platelet-derived growth factor |
US5190859A (en) * | 1987-02-26 | 1993-03-02 | Dana-Farber Cancer Institute, Inc. | Purification of LFA-3 |
SE468653B (sv) * | 1987-03-06 | 1993-02-22 | Perstorp Biolytica | Adsorbent foer isokratisk affinitetskromatografi |
JPS6463599A (en) * | 1987-05-01 | 1989-03-09 | Xoma Corp | Purification of immunoglobulin by selective anti-idiotype bond |
JPH03500682A (ja) * | 1987-07-14 | 1991-02-14 | ザ ビクトリア ユニヴアーシテイ オブ マンチエスター | 診断方法 |
CA1323567C (en) * | 1987-10-05 | 1993-10-26 | Gene R. Nathans | Method for purification of antibodies |
US5582862A (en) | 1988-04-04 | 1996-12-10 | General Hospital Corporation | Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin |
US5372812A (en) * | 1988-04-04 | 1994-12-13 | The General Hospital Corporation | Composition and method for acceleration of clot lysis |
JP2001502895A (ja) * | 1996-09-20 | 2001-03-06 | ザ・ジェネラル・ホスピタル・コーポレイション | アルファ―2―抗プラスミンに対するキメラ、ヒト化および一本鎖抗体 |
ES2563483T3 (es) * | 2008-04-11 | 2016-03-15 | Chugai Seiyaku Kabushiki Kaisha | Molécula de unión a antígeno capaz de unirse repetidamente a dos o más moléculas de antígeno |
US20140234340A1 (en) | 2010-11-30 | 2014-08-21 | Chugai Seiyaku Kabushiki Kaisha | Antigen-binding molecule capable of binding to plurality of antigen molecules repeatedly |
SG10201609665PA (en) | 2011-02-25 | 2017-01-27 | Chugai Pharmaceutical Co Ltd | FcɣRIIb-SPECIFIC Fc ANTIBODY |
JP6322411B2 (ja) | 2011-09-30 | 2018-05-09 | 中外製薬株式会社 | 複数の生理活性を有する抗原の消失を促進する抗原結合分子 |
CA3233142A1 (en) | 2011-11-30 | 2013-06-06 | Chugai Seiyaku Kabushiki Kaisha | Drug containing carrier into cell for forming immune complex |
KR20230044338A (ko) | 2014-12-19 | 2023-04-03 | 추가이 세이야쿠 가부시키가이샤 | 항-c5 항체 및 그의 사용 방법 |
SG11201700841QA (en) | 2014-12-19 | 2017-03-30 | Chugai Pharmaceutical Co Ltd | Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use |
JP7141336B2 (ja) | 2015-12-25 | 2022-09-22 | 中外製薬株式会社 | 抗ミオスタチン抗体および使用方法 |
CA3026050A1 (en) | 2016-08-05 | 2018-02-08 | Chugai Seiyaku Kabushiki Kaisha | Composition for prophylaxis or treatment of il-8 related diseases |
EP3574010A4 (en) | 2017-01-30 | 2020-12-16 | Chugai Seiyaku Kabushiki Kaisha | ANTI-SCLEROSTIN ANTIBODIES AND METHOD OF USE |
CN110724204B (zh) * | 2019-11-18 | 2021-10-22 | 广东菲鹏制药股份有限公司 | Fc融合蛋白的纯化方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4172124A (en) * | 1978-04-28 | 1979-10-23 | The Wistar Institute | Method of producing tumor antibodies |
ATE14269T1 (de) * | 1981-02-26 | 1985-08-15 | Unilever Nv | Verfahren und vorrichtung zur rueckgewinnung von immunoglobulinen. |
US4474893A (en) * | 1981-07-01 | 1984-10-02 | The University of Texas System Cancer Center | Recombinant monoclonal antibodies |
US4361509A (en) * | 1981-12-14 | 1982-11-30 | Scripps Clinic And Research Foundation | Ultrapurification of factor VIII using monoclonal antibodies |
-
1983
- 1983-04-11 ES ES521371A patent/ES8404858A1/es not_active Expired
- 1983-04-11 CA CA000425555A patent/CA1209907A/en not_active Expired
- 1983-04-12 IT IT20550/83A patent/IT1219779B/it active
- 1983-04-12 EP EP19830901671 patent/EP0105359A4/en not_active Withdrawn
- 1983-04-12 CH CH6699/83A patent/CH672028A5/de not_active IP Right Cessation
- 1983-04-12 AT AT9019/83A patent/AT393386B/de not_active IP Right Cessation
- 1983-04-12 GB GB08332644A patent/GB2128630B/en not_active Expired
- 1983-04-12 WO PCT/US1983/000524 patent/WO1983003678A1/en not_active Application Discontinuation
- 1983-12-09 FI FI834530A patent/FI88403C/fi not_active IP Right Cessation
- 1983-12-13 ES ES528001A patent/ES8706964A1/es not_active Expired
- 1983-12-13 ES ES528000A patent/ES528000A0/es active Granted
-
1987
- 1987-05-06 AU AU72569/87A patent/AU622099B2/en not_active Ceased
-
1991
- 1991-11-26 DK DK911921A patent/DK192191D0/da not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA1209907A (en) | 1986-08-19 |
ES8506902A1 (es) | 1985-08-01 |
ES528000A0 (es) | 1985-08-01 |
ES521371A0 (es) | 1984-05-16 |
AT393386B (de) | 1991-10-10 |
AU7256987A (en) | 1987-09-03 |
FI88403C (fi) | 1993-05-10 |
FI88403B (fi) | 1993-01-29 |
EP0105359A1 (en) | 1984-04-18 |
FI834530A0 (fi) | 1983-12-09 |
ATA901983A (de) | 1991-03-15 |
ES8706964A1 (es) | 1987-07-01 |
GB2128630A (en) | 1984-05-02 |
DK192191A (da) | 1991-11-26 |
IT1219779B (it) | 1990-05-24 |
EP0105359A4 (en) | 1984-08-20 |
DK192191D0 (da) | 1991-11-26 |
GB8332644D0 (en) | 1984-01-11 |
WO1983003678A1 (en) | 1983-10-27 |
AU622099B2 (en) | 1992-04-02 |
IT8320550A0 (it) | 1983-04-12 |
FI834530A (fi) | 1983-12-09 |
CH672028A5 (es) | 1989-10-13 |
ES528001A0 (es) | 1987-07-01 |
GB2128630B (en) | 1986-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES8706964A1 (es) | Un procedimiento para fraccionar anticuerpos de suero. | |
ES8206856A1 (es) | Mejoras en un metodo y su correspondiente equipo de ensayo para determinar antigenos por medio de una reaccion inmuno- quimica | |
AU1964883A (en) | Monoclonal antibody immunoassay | |
ES2106195T3 (es) | Anticuerpo igg aglicosilado anti cd3. | |
EP0098162A3 (en) | Monoclonal antibodies specific to carcinoembryonic antigen | |
DK0432249T3 (da) | Monoklonale antistoffer over for beta-kæden i leukocytadhæsionsreceptoren, fremgangsmåder til fremstilling af disse antistoffer og anvendelse heraf | |
MY101457A (en) | Toxins and antibodies of c.difficile. | |
AU564575B2 (en) | Polyvalent endotoxin specific antibodies | |
AU567681B2 (en) | Immunoassay involving monoclonal igm antibody | |
MY100328A (en) | Toxins and antibodies of c.difficile | |
EP0287397A3 (en) | Monoclonal antibody specific to human pancreatic phospholipase a2 | |
CA2054689A1 (en) | An immunoassay method for determining the specificity of binding of a monoclonal antibody to an antigen | |
ES8401261A1 (es) | Soportes de materia plastica revestidos de un segundo anticuerpo. | |
ES8704351A1 (es) | Un procedimiento para preparar un anticuerpo monocional anti-urocinasa. | |
EP0186371A3 (en) | Monoclonal antibodies specific to antigens of hepatitis b virus | |
AU2900184A (en) | Membrane antigens generated from pooled cells and monoclonal antibodies | |
EP0089771A3 (en) | Atcc hb8116 and its monoclonal anti-h-y antibody, hyclonalan | |
AU1550783A (en) | Method of affinity purification employing monoclonal antibodies | |
DE3174878D1 (en) | Immunoassay utilizing monoclonal high affinity igm antibodies | |
CA2178504A1 (en) | Immunoassays for prostate specific antigen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 19970401 |